• PharmaTher entered a collaboration with Craft Health to evaluate the CraftMake GMP-ready pharmaceutical 3D printing platform for personalized peptides.
• Work will target new peptide formulations, reproducibility for personalized dosing, combination products, controlled-release designs, differentiated dosage forms.
• PharmaTher will assess a broader commercial relationship to deploy CraftMake with qualified Section 503A compounding pharmacies for its Personaliz3D Peptides initiative.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmather Holdings Ltd. published the original content used to generate this news brief on July 29, 2026, and is solely responsible for the information contained therein.